Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group
  2. Taxonomy
  3. Term
  4. Other

Strategies for safety reporting in substance abuse trials.

Go back to Resources

Strategies for safety reporting in substance abuse trials.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Evaluation of HIV-1 MN recombinant gp160 candidate vaccine,

Go back to Resources

Evaluation of HIV-1 MN recombinant gp160 candidate vaccine,

Authors:

Location:

Go back to Resources

Growth post transplantation (Tx) - Long term analysis by the North American Pediatric Renal Transplant Cooperative Study,

Go back to Resources

Growth post transplantation (Tx) - Long term analysis by the North American Pediatric Renal Transplant Cooperative Study,

Authors:

Location:

Go back to Resources

Fourth annual survey of worldwide HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates,

Go back to Resources

Fourth annual survey of worldwide HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Meeting Highlights: A Reappraisal of Research Results For the Local Treatment of Early Stage Breast Cancer

Go back to Resources

Meeting Highlights: A Reappraisal of Research Results For the Local Treatment of Early Stage Breast Cancer

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Go back to Resources

Impact of HLA matching, type of crossmatch and immunosuppresive therapy on primary pediatric cadaver renal allograft survival,

Go back to Resources

Impact of HLA matching, type of crossmatch and immunosuppresive therapy on primary pediatric cadaver renal allograft survival,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Analysis of rejection outcomes and implications. A report of the North American Pediatric Renal Transplant Cooperative Study,

Go back to Resources

Analysis of rejection outcomes and implications. A report of the North American Pediatric Renal Transplant Cooperative Study,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Alternate-day steroid dosing improves growth without adversely affecting graft survival or long-term graft function,

Go back to Resources

Alternate-day steroid dosing improves growth without adversely affecting graft survival or long-term graft function,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

AIDS dementia complex in the Italian National AIDS Registry: temporal trends (1987-93) and differential incidence according to mode of transmission of HIV-1 infection,

Go back to Resources

AIDS dementia complex in the Italian National AIDS Registry: temporal trends (1987-93) and differential incidence according to mode of transmission of HIV-1 infection,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Adjusting Moran’s I for population density,

Go back to Resources

Adjusting Moran’s I for population density,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Pagination

  • Previous page ‹‹
  • Page 99
  • Next page ››
Subscribe to Other
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification